3月5日,H&H国际控股(01112)发布公告,报告截至2024年12月31日止年度的未审计业务及财务表现。根据公告内容,集团总收入较去年录得约中单位数降幅,主要受高利润且迅速增长的营养补充品推动,尤其是维生素、草本及矿物补充剂以及宠物补充品实现双位数增幅。然而,婴幼儿配方奶粉分部的下滑对整体收入造成了抵消影响。财务动态方面,预计截至2024年12月31日止年度的经调整可比EBITDA将较去年录得...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.